| 000 | 01599 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515211555.0 | ||
| 264 | 0 | _c20100323 | |
| 008 | 201003s 0 0 eng d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJones, Tisa McCready | |
| 245 | 0 | 0 |
_aPharmaceuticals and medical devices: business practices. End-of-year issue brief. _h[electronic resource] |
| 260 |
_bIssue brief (Health Policy Tracking Service) _cJan 2010 |
||
| 300 |
_a1-58 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdvertising _xeconomics |
| 650 | 0 | 4 | _aAuthorship |
| 650 | 0 | 4 | _aBiological Products |
| 650 | 0 | 4 |
_aCommerce _xethics |
| 650 | 0 | 4 |
_aCommunity Participation _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aConflict of Interest _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aCosts and Cost Analysis _xethics |
| 650 | 0 | 4 |
_aData Mining _xethics |
| 650 | 0 | 4 |
_aDisclosure _xethics |
| 650 | 0 | 4 |
_aDrug Costs _xethics |
| 650 | 0 | 4 |
_aDrug Industry _xethics |
| 650 | 0 | 4 |
_aEducation, Medical, Continuing _xethics |
| 650 | 0 | 4 | _aEthics, Business |
| 650 | 0 | 4 | _aEthics, Professional |
| 650 | 0 | 4 | _aFederal Government |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLegislation, Drug _xethics |
| 650 | 0 | 4 |
_aMarketing of Health Services _xethics |
| 650 | 0 | 4 |
_aOrphan Drug Production _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aPatents as Topic _xethics |
| 650 | 0 | 4 |
_aPersonnel Downsizing _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aState Government |
| 650 | 0 | 4 |
_aTruth Disclosure _xethics |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tIssue brief (Health Policy Tracking Service) _gp. 1-58 |
|
| 999 |
_c19580933 _d19580933 |
||